Featuring a similar structure to the MHC class I molecule, the neonatal Fc receptor is an Fc receptor that forms a heterodimer protein with beta-2-microglobulin. It was initially identified in rodents ...
The FDA’s related initiatives in Process Analytic Technology (PAT) and Quality by Design (QbD) remain, nearly 20 years after their promulgation, largely unrealized. The technology exists for biopharma ...
CD20 is a potential target for the treatment of leukemia, lymphoma, and some autoimmune diseases. However, due to the complexity of expression and the unstable bioactivity, it is very hard to find an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback